.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 8,221,365

« Back to Dashboard

Details for Patent: 8,221,365

Title:Disinfectant delivery system, and method of providing alcohol-free disinfection
Abstract: A disinfectant delivery system and method of providing alcohol-free disinfection to a body to be disinfected, as well as a method of infection reduction by preparation of a patient before an invasive procedure. A blended cloth comprising first fibers and second fibers is provided with the first fibers generally being greater in quantity by weight than the second fibers. A disinfectant solution impregnates the blended cloth, with the disinfectant solution having chlorhexidine gluconate as an active ingredient and having no alcohol. In the method according to the invention, at least one impregnated blended cloth is used to disinfect at least a portion of a body. A plurality of blended cloths can be provided for disinfecting discrete portions of the body. When an invasive procedure is to be performed on a patient, a further method according to the invention of infection reduction comprises using a CHG-impregnated cloth to disinfect at least a portion of the patient at least one day prior to the invasive procedure proximate the location of the invasive procedure.
Inventor(s): Keaty, Jr.; Thomas (Crystal Lake, IL), Skiba; Barbara T. (Chicago, IL), Hanifl; Paul H. (Barrington Hills, IL)
Assignee: Sage Products, Inc. (Cary, IL)
Filing Date:Apr 27, 2010
Application Number:12/767,923
Claims:1. A method of infection reduction by preparation of a patient before an invasive procedure, comprising a. providing a first blended cloth comprising a fibrous mat impregnated with a first disinfecting solution having chlorhexidine gluconate (CHG) as an active ingredient and having no alcohol, and b. using the first impregnated cloth to disinfect at least a portion of the patient at least one day prior to, and up to several days prior to, the invasive procedure proximate the invasive procedure, wherein substantially all of the chlorhexidine gluconate (CHG) in the first disinfecting solution is released from the first blended cloth during the method step "b", c. providing a second blended cloth comprising a fibrous mat impregnated with a second disinfecting solution having chlorhexidine gluconate (CHG) as an active ingredient and having no alcohol, and d. using the second impregnated cloth to disinfect at least a portion of the patient at the time of the invasive procedure proximate the invasive procedure, wherein the first blended cloth comprises first fibers and second fibers, with the quantity by weight of said first fibers generally being greater than the quantity by weight of the second fibers, said first blended cloth having an absorbency by weight greater than the weight of said first blended cloth, and wherein the second blended cloth comprises first fibers and second fibers, with the quantity by weight of said first fibers generally being greater than the quantity by weight of the second fibers, said second blended cloth having an absorbency by weight greater than the weight of said second blended cloth.

2. The method according to claim 1, in which the first fibers of the first blended cloth comprise polyester fibers.

3. The method according to claim 1, in which the second fibers of the first blended cloth comprise polyester fibers.

4. The method according to claim 1, in which the first fibers of the second blended cloth comprise polyester fibers.

5. The method according to claim 1, in which the second fibers of the second blended cloth comprise polyester fibers.

6. A method of infection reduction by preparation of a patient before an invasive procedure, comprising a. providing a first blended cloth comprising a fibrous mat impregnated with a first disinfecting solution having chlorhexidine gluconate (CHG) as an active ingredient and having no alcohol, and b. using the first impregnated cloth to disinfect at least a portion of the patient at least one day prior to, and up to several days prior to, the invasive procedure proximate the invasive procedure, c. providing a second blended cloth comprising a fibrous mat impregnated with a second disinfecting solution having chlorhexidine gluconate (CHG) as an active ingredient and having no alcohol, and d. using the second impregnated cloth to disinfect at least a portion of the patient at the time of the invasive procedure proximate the invasive procedure, wherein substantially all of the chlorhexidine gluconate (CHG) in the second disinfecting solution is released from the second blended cloth during the method step "d", and wherein the first blended cloth comprises first fibers and second fibers, with the quantity by weight of said first fibers generally being greater than the quantity by weight of the second fibers, said first blended cloth having an absorbency by weight greater than the weight of said first blended cloth, and wherein the second blended cloth comprises first fibers and second fibers, with the quantity by weight of said first fibers generally being greater than the quantity by weight of the second fibers, said second blended cloth having an absorbency by weight greater than the weight of said second blended cloth.

7. The method according to claim 6, in which the first fibers of the first blended cloth comprise polyester fibers.

8. The method according to claim 6, in which the second fibers of the first blended cloth comprise polyester fibers.

9. The method according to claim 6, in which the first fibers of the second blended cloth comprise polyester fibers.

10. The method according to claim 6, in which the second fibers of the second blended cloth comprise polyester fibers.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc